Study director. 1.2.1 RGI shall appoint a study director ("Study Director") to be responsible to oversee the completion of each Study by RGI. The Study Director shall coordinate performance of the applicable Study with a representative designated by GSK ("GSK Representative"), which GSK Representative shall have responsibility over all matters relating to the performance of such Study on behalf of GSK.
Appears in 1 contract
Study director. 1.2.1 RGI shall appoint a study director ("Study Director") to be responsible to oversee the completion of each Study by RGI. The Study Director shall coordinate performance of the applicable Study with a representative designated by GSK ("GSK Representative"), which GSK Representative shall have responsibility over all matters relating to the performance of such Study on behalf of GSK. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act.
Appears in 1 contract
Study director. 1.2.1 RGI shall appoint a study director ("Study Director") to be responsible to oversee the completion of each Study by RGI. The Study Director shall coordinate performance of the applicable Study with a representative designated by GSK BIO ("GSK BIO Representative"), which GSK BIO Representative shall have responsibility over all matters relating to the performance of such Study on behalf of GSKGSK BIO.
Appears in 1 contract
Study director. 1.2.1 (a) RGI shall appoint a study director ("“Study Director"”) to be responsible to oversee the completion of each Study by RGI. The Study Director shall coordinate performance of the applicable Study with a representative designated by GSK BIO ("“GSK BIO Representative"”), which GSK BIO Representative shall have responsibility over all matters relating to the performance of such Study on behalf of GSKGSK BIO.
Appears in 1 contract